LIBYTEC PHARMACEUTICAL S.A. was founded in June 2008 with the aim to offer, in regards of health, credible modern proprietary pharmaceuticals.
From 1/1/2010 Mr. Theodoros Koletis has undertaken the company as the President and CEO. He has served as the President of the Panhellenic Pharmaceutical Union and has an extensive presence in the health sector.
He represents a modern concept in the health sector, responding to the modern requirements.
The company has a remarkable portfolio of drugs in many therapeutic categories.
Thus, there are available on the Greek market:
- Quality pharmaceuticals of high therapeutic value.
- Innovative active substances which "make the difference" in their therapeutic class.